ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

Guest Editorial – Interlocking Tragedies: Lance Armstrong and CPRIT

February 15, 2013

DeCosse: Colorectal Screening Could Save 6,000 Lives Per Year

November 29, 1991

Funding Opportunities. (8-page issue).

May 2, 2003

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006

NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests

November 21, 1975